Bajaj Healthcare Ltd (BAJAJHCARE) is currently trading at 346.55 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Bajaj Healthcare Limited is a major pharmaceutical manufacturer specializing in APIs, finished dosage forms, and nutraceuticals. It operates 20 state-of-the-art manufacturing facilities and exports products to over 60 countries. In FY 2025, Bajaj Healthcare achieved a total income of Rs 562.01 Cr, showcasing resilience amid challenging market conditions. The company maintains a net worth of Rs 486.39 Cr, illustrating a sound financial position. Bajaj Healthcare's strategic acquisition of Genrx Pharmaceuticals Private Limited marks a significant growth step, reinforcing its market presence and operational capacities. With a robust R&D pipeline, Bajaj Healthcare focuses on peptide synthesis and aims commercialization by March 2026, emphasizing its commitment to innovation and expanding global demand. Its CDMO partnership with UK/EU clients highlights Bajaj Healthcare's strategic move to enhance international collaborations, ensuring a foothold in lucrative markets and exclusive medicinal manufacturing.

Over the past 52 weeks, Bajaj Healthcare Ltd has traded between a low of ₹346.15 and a high of ₹744.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Bajaj Healthcare Ltd has a market capitalization of approximately 1,137.00. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Bajaj Healthcare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 21.74 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

You can buy shares of Bajaj Healthcare Ltd (BAJAJHCARE) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.

Based on its market capitalization of 1,137.00 Cr, Bajaj Healthcare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Bajaj Healthcare Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Bajaj Healthcare Ltd is 21.74. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Bajaj Healthcare Ltd pays dividends with a current dividend yield of 0.28%. Dividend-paying stocks may provide periodic income in addition to potential long-term capital appreciation.

Key risks associated with Bajaj Healthcare Ltd include sector-specific challenges in the Pharmaceuticals industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.